Kyverna Therapeutics, Inc. Number of Operating Segments
Kyverna Therapeutics, Inc. (KYTX) reported Number of Operating Segments of 1 Segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfOperatingSegments · last filed 2026-08-11
- Kyverna Therapeutics, Inc. number of operating segments for the quarter ending 2026-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Kyverna Therapeutics, Inc. number of operating segments for the quarter ending 2025-03-31 was 1.00 Segment, a 0.00% change year-over-year.
- Kyverna Therapeutics, Inc. number of operating segments for the quarter ending 2024-03-31 was 1.00 Segment.
- Kyverna Therapeutics, Inc. number of operating segments for fiscal 2025 was 1.00 Segment, a 0.00% change from fiscal 2024.
- Kyverna Therapeutics, Inc. number of operating segments for fiscal 2024 was 1.00 Segment.
| Period end | Number of Operating Segments 3 month | Number of Operating Segments 6 month | Number of Operating Segments 9 month | Number of Operating Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 Segment 10-Q · filed 2026-08-11 | |||
| 2026-03-31 | 1.00 Segment 10-Q · filed 2026-05-12 | |||
| 2025-12-31 | 1.00 Segment 10-K · filed 2026-03-26 | |||
| 2025-09-30 | 1.00 Segment 10-Q · filed 2025-11-12 | |||
| 2025-06-30 | 1.00 Segment 10-Q · filed 2025-08-12 | |||
| 2025-03-31 | 1.00 Segment 10-Q · filed 2025-05-13 | |||
| 2024-12-31 | 1.00 Segment 10-K · filed 2025-03-27 | |||
| 2024-09-30 | 1.00 Segment 10-Q · filed 2024-11-13 | |||
| 2024-06-30 | 1.00 Segment 10-Q · filed 2024-08-12 | |||
| 2024-03-31 | 1.00 Segment 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |